Surmodics Reports First Quarter Fiscal 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
SurModics (SRDX) PT Lowered to $69 at Needham & Company
January 31, 2019 8:26 AM ESTNeedham & Company analyst Mike Matson lowered the price target on SurModics (NASDAQ: SRDX) to $69.00 (from $74.00) while maintaining a Buy rating.
Matson commented, "RDX beat consensus F1Q19 revenue and EPS estimates. Management raised the lower end of its FY19 revenue guidance and narrowed... More
SurModics (SRDX) Reports Q1 EPS of $0.12, Revenues Beat; Raises FY19 EPS/Revenue Mid-Point Guidance Above Consensus
January 30, 2019 4:31 PM ESTSurModics (NASDAQ: SRDX) reported Q1 EPS of $0.12, versus $0.10 reported last year. Revenue for the quarter came in at $22.2 million versus the consensus estimate of $20.18 million.
Revenue of $22.2 million, an increase of 31% year-over-yearGAAP EPS of $0.09, non-GAAP EPS of $0.12Updating fiscal 2019... More